Samsung Announces Move into Biomedical Business

Feb. 25, 2011
Will produce drugs for cancer and arthritis patients at biopharmaceutical plant in Seoul

Samsung will invest $266 million in a pharmaceutical joint venture, as part of a ten-year multi-billion dollar attempt to develop new growth engines.

Samsung said work would start in the first half of this year on a biopharmaceutical production plant at Songdo International City, part of the Incheon Free Economic Zone west of Seoul.It said that production of drugs for cancer and arthritis patients was expected to start in the first half of 2013.

Samsung Electronics and Samsung Everland would each own 40% of the joint venture, Samsung C and T would have 10% and U.S.-based pharmaceutical multinational Quintiles would own the remaining 10%.

Samsung, which accounts for 20% of the country's exports, in May last year announced plans to invest 23 trillion won in healthcare and green energy over the next decade. Some 2.1 trillion of the total was earmarked for biopharmaceuticals and today's announcement signaled the first major step in those plans.

Samsung said it would initially be engaged in contract manufacturing but planned in the longer term to develop its own products.

Copyright Agence France-Presse, 2011

See Also
Samsung Investing $38.3 Billion in 2011 to Get Ahead of Rivals

Popular Sponsored Recommendations

Digital Transformation at Nestlé Purina

March 24, 2024
Nestlé Purina deployed Spot to automate thermal and acoustic inspections in their packaging lines. Autonomous inspections allow them to give time back to the maintenance technicians...

Disruptive EV Technologies Are Driving New Supplier Realities

Sept. 20, 2023
Vehicle electrification is upending the automotive landscape, forcing suppliers to make critical strategic and operational decisions. Understand what that means for you in our...

Decarbonizing Your Supply Chain: Striving for Net Zero

Feb. 12, 2024
Manufacturers face mounting pressure to decarbonize operations and supply chains. Meeting regulatory goals demands bold action and transparency. Collaboration with suppliers offers...

Guide to Dedicated Contract Carriage

May 27, 2022
Is DCC (Dedicated Contact Carriage) right for your business? It could be a way for shippers like you to reduce costs, ensure truck capacity and reduce risk. The more you know ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!